Index by author

01 January 2003; volume 21, issue 1

A

  1. Abdel Kafi, S.

    1. Fesler, P. et al "Single arterial occlusion to locate resistance in patients with pulmonary hypertension." European Respiratory Journal 21.1 (2003): 31-36. Web. 16 Oct. 2019.

  2. Adamek, L.

    1. Nizankowska-Mogilnicka, E. et al "Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis." European Respiratory Journal 21.1 (2003): 25-30. Web. 16 Oct. 2019.

  3. Alonso, J.

    1. Hernandez, C. et al "Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients." European Respiratory Journal 21.1 (2003): 58-67. Web. 16 Oct. 2019.

  4. Alton, E.W.F.W.

    1. McShane, D. et al "Airway surface pH in subjects with cystic fibrosis." European Respiratory Journal 21.1 (2003): 37-42. Web. 16 Oct. 2019.

  5. Alving, K.

    1. Zetterquist, W., J.O.N. Lundberg, and K. Alving. "Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis." European Respiratory Journal 21.1 (2003): 197-198. Web. 16 Oct. 2019.

  6. Angner, R.

    1. Baumgartner, R.A. et al "Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone." European Respiratory Journal 21.1 (2003): 123-128. Web. 16 Oct. 2019.

B

  1. Barbee, R.

    1. Sherrill, D. et al "The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics." European Respiratory Journal 21.1 (2003): 95-10. Web. 16 Oct. 2019.

  2. Barnes, P.J.

    1. Paredi, P., S.A. Kharitonov, and P.J. Barnes. "Exhaled breath temperature in asthma." European Respiratory Journal 21.1 (2003): 195. Web. 16 Oct. 2019.
    2. Paredi, P., S.A. Kharitonov, and P.J. Barnes. "Exhaled carbon monoxide in lung disease." European Respiratory Journal 21.1 (2003): 197. Web. 16 Oct. 2019.
    3. Wodehouse, T. et al "Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia." European Respiratory Journal 21.1 (2003): 43-47. Web. 16 Oct. 2019.

  3. Barst, R.J.

    1. Widlitz, A., and R.J. Barst. "Pulmonary arterial hypertension in children." European Respiratory Journal 21.1 (2003): 155-176. Web. 16 Oct. 2019.

  4. Baumgartner, R.A.

    1. Baumgartner, R.A. et al "Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone." European Respiratory Journal 21.1 (2003): 123-128. Web. 16 Oct. 2019.

  5. Bejjani, G.

    1. Hubloue, I. et al "Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction." European Respiratory Journal 21.1 (2003): 19-24. Web. 16 Oct. 2019.

  6. Berger, K.

    1. Schramm, B. et al "Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1‐yr retrospective study." European Respiratory Journal 21.1 (2003): 116-122. Web. 16 Oct. 2019.

  7. Bernstein, M.

    1. Baumgartner, R.A. et al "Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone." European Respiratory Journal 21.1 (2003): 123-128. Web. 16 Oct. 2019.

  8. Besozzi, G.

    1. Migliori, G.B. et al "Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998–2000." European Respiratory Journal 21.1 (2003): 129-134. Web. 16 Oct. 2019.

  9. Biarent, D.

    1. Hubloue, I. et al "Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction." European Respiratory Journal 21.1 (2003): 19-24. Web. 16 Oct. 2019.

  10. Bird, S.

    1. Baumgartner, R.A. et al "Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone." European Respiratory Journal 21.1 (2003): 123-128. Web. 16 Oct. 2019.

  11. Boaron, M.

    1. Bonaccorsi, A. et al "Acute interstitial pneumonia: report of a series." European Respiratory Journal 21.1 (2003): 187-191. Web. 16 Oct. 2019.

  12. Bobadilla, A.

    1. Sherrill, D. et al "The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics." European Respiratory Journal 21.1 (2003): 95-10. Web. 16 Oct. 2019.

  13. Bodini, A.

    1. Piacentini, G.L. et al "From the Authors." European Respiratory Journal 21.1 (2003): 196. Web. 16 Oct. 2019.

  14. Bonaccorsi, A.

    1. Bonaccorsi, A. et al "Acute interstitial pneumonia: report of a series." European Respiratory Journal 21.1 (2003): 187-191. Web. 16 Oct. 2019.

  15. Boner, A.L.

    1. Piacentini, G.L. et al "From the Authors." European Respiratory Journal 21.1 (2003): 196. Web. 16 Oct. 2019.

  16. Boonstra, A.

    1. Roeleveld, R.J. et al "Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung." European Respiratory Journal 21.1 (2003): 192-194. Web. 16 Oct. 2019.
    2. Fesler, P. et al "Single arterial occlusion to locate resistance in patients with pulmonary hypertension." European Respiratory Journal 21.1 (2003): 31-36. Web. 16 Oct. 2019.

  17. Boveri, B.

    1. Santus, P. et al "Bronchodilation test in COPD: effect of inspiratory manoeuvre preceding forced expiration." European Respiratory Journal 21.1 (2003): 82-85. Web. 16 Oct. 2019.
    2. Di Marco, F. et al "Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD." European Respiratory Journal 21.1 (2003): 86-94. Web. 16 Oct. 2019.

  18. Brimioulle, S.

    1. Fesler, P. et al "Single arterial occlusion to locate resistance in patients with pulmonary hypertension." European Respiratory Journal 21.1 (2003): 31-36. Web. 16 Oct. 2019.

  19. Burge, P.S.

    1. Jones, P.W. et al "Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations." European Respiratory Journal 21.1 (2003): 68-73. Web. 16 Oct. 2019.

  20. Bush, A.

    1. McShane, D. et al "Airway surface pH in subjects with cystic fibrosis." European Respiratory Journal 21.1 (2003): 37-42. Web. 16 Oct. 2019.

C

  1. Calverley, P.M.A.

    1. Jones, P.W. et al "Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations." European Respiratory Journal 21.1 (2003): 68-73. Web. 16 Oct. 2019.

  2. Cancellieri, A.

    1. Bonaccorsi, A. et al "Acute interstitial pneumonia: report of a series." European Respiratory Journal 21.1 (2003): 187-191. Web. 16 Oct. 2019.

  3. Carlucci, P.

    1. Santus, P. et al "Bronchodilation test in COPD: effect of inspiratory manoeuvre preceding forced expiration." European Respiratory Journal 21.1 (2003): 82-85. Web. 16 Oct. 2019.
    2. Di Marco, F. et al "Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD." European Respiratory Journal 21.1 (2003): 86-94. Web. 16 Oct. 2019.

  4. Casanova, F.

    1. Di Marco, F. et al "Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD." European Respiratory Journal 21.1 (2003): 86-94. Web. 16 Oct. 2019.

  5. Casas, A.

    1. Hernandez, C. et al "Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients." European Respiratory Journal 21.1 (2003): 58-67. Web. 16 Oct. 2019.

  6. Cassone, A.

    1. Migliori, G.B. et al "Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998–2000." European Respiratory Journal 21.1 (2003): 129-134. Web. 16 Oct. 2019.

  7. Castagna, F.

    1. Santus, P. et al "Bronchodilation test in COPD: effect of inspiratory manoeuvre preceding forced expiration." European Respiratory Journal 21.1 (2003): 82-85. Web. 16 Oct. 2019.

  8. Cataneo, R.N.

    1. Phillips, M. et al "Effect of oxygen on breath markers of oxidative stress." European Respiratory Journal 21.1 (2003): 48-51. Web. 16 Oct. 2019.

  9. Cazzola, M.

    1. Di Marco, F. et al "Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD." European Respiratory Journal 21.1 (2003): 86-94. Web. 16 Oct. 2019.

  10. Centanni, S.

    1. Santus, P. et al "Bronchodilation test in COPD: effect of inspiratory manoeuvre preceding forced expiration." European Respiratory Journal 21.1 (2003): 82-85. Web. 16 Oct. 2019.
    2. Di Marco, F. et al "Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD." European Respiratory Journal 21.1 (2003): 86-94. Web. 16 Oct. 2019.

  11. Centis, R.

    1. Migliori, G.B. et al "Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998–2000." European Respiratory Journal 21.1 (2003): 129-134. Web. 16 Oct. 2019.

  12. Channick, R.N.

    1. Fesler, P. et al "Single arterial occlusion to locate resistance in patients with pulmonary hypertension." European Respiratory Journal 21.1 (2003): 31-36. Web. 16 Oct. 2019.

  13. Chilosi, M.

    1. Bonaccorsi, A. et al "Acute interstitial pneumonia: report of a series." European Respiratory Journal 21.1 (2003): 187-191. Web. 16 Oct. 2019.

  14. Cole, P.J.

    1. Wodehouse, T. et al "Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia." European Respiratory Journal 21.1 (2003): 43-47. Web. 16 Oct. 2019.

  15. Collvinent, B.

    1. Hernandez, C. et al "Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients." European Respiratory Journal 21.1 (2003): 58-67. Web. 16 Oct. 2019.

  16. Corris, P.

    1. Torres, A. et al "Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia." European Respiratory Journal 21.1 (2003): 135-143. Web. 16 Oct. 2019.

  17. Costabel, U.

    1. Ratjen, F. et al "Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis." European Respiratory Journal 21.1 (2003): 144-148. Web. 16 Oct. 2019.

  18. Costella, S.

    1. Piacentini, G.L. et al "From the Authors." European Respiratory Journal 21.1 (2003): 196. Web. 16 Oct. 2019.

  19. Crimi, N.

    1. Bonaccorsi, A. et al "Acute interstitial pneumonia: report of a series." European Respiratory Journal 21.1 (2003): 187-191. Web. 16 Oct. 2019.

  20. Cukier, A.

    1. Szafranski, W. et al "Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease." European Respiratory Journal 21.1 (2003): 74-81. Web. 16 Oct. 2019.

D

  1. Dass, S.B.

    1. Baumgartner, R.A. et al "Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone." European Respiratory Journal 21.1 (2003): 123-128. Web. 16 Oct. 2019.

  2. Davies, J.C.

    1. McShane, D. et al "Airway surface pH in subjects with cystic fibrosis." European Respiratory Journal 21.1 (2003): 37-42. Web. 16 Oct. 2019.

  3. Davies, M.G.

    1. McShane, D. et al "Airway surface pH in subjects with cystic fibrosis." European Respiratory Journal 21.1 (2003): 37-42. Web. 16 Oct. 2019.

  4. Delcroix, M.

    1. Fesler, P. et al "Single arterial occlusion to locate resistance in patients with pulmonary hypertension." European Respiratory Journal 21.1 (2003): 31-36. Web. 16 Oct. 2019.

  5. Demedts, M.

    1. Put, C. et al "Evaluation of an individualised asthma programme directed at behavioural change." European Respiratory Journal 21.1 (2003): 109-115. Web. 16 Oct. 2019.

  6. De Swert, K.O.

    1. Tournoy, K.G. et al "Modulatory role of tachykinin NK1 receptor in cholinergic contraction of mouse trachea." European Respiratory Journal 21.1 (2003): 3-10. Web. 16 Oct. 2019.

  7. Di Marco, F.

    1. Santus, P. et al "Bronchodilation test in COPD: effect of inspiratory manoeuvre preceding forced expiration." European Respiratory Journal 21.1 (2003): 82-85. Web. 16 Oct. 2019.
    2. Di Marco, F. et al "Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD." European Respiratory Journal 21.1 (2003): 86-94. Web. 16 Oct. 2019.

  8. Domagala, T.B.

    1. Nizankowska-Mogilnicka, E. et al "Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis." European Respiratory Journal 21.1 (2003): 25-30. Web. 16 Oct. 2019.

  9. Duprat-Lomon, I.

    1. Torres, A. et al "Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia." European Respiratory Journal 21.1 (2003): 135-143. Web. 16 Oct. 2019.

E

  1. Edelman, J.M.

    1. Baumgartner, R.A. et al "Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone." European Respiratory Journal 21.1 (2003): 123-128. Web. 16 Oct. 2019.

  2. Ehlken, B.

    1. Schramm, B. et al "Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1‐yr retrospective study." European Respiratory Journal 21.1 (2003): 116-122. Web. 16 Oct. 2019.

  3. Eklund, A.

    1. Planck, A., A. Eklund, and J. Grunewald. "Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients." European Respiratory Journal 21.1 (2003): 52-57. Web. 16 Oct. 2019.

  4. Ernst, P.

    1. Suissa, S., and P. Ernst. "Use of anti-inflammatory therapy and asthma mortality in Japan." European Respiratory Journal 21.1 (2003): 101-104. Web. 16 Oct. 2019.

  5. Escarrabill, J.

    1. Hernandez, C. et al "Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients." European Respiratory Journal 21.1 (2003): 58-67. Web. 16 Oct. 2019.

F

  1. Farrero, E.

    1. Hernandez, C. et al "Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients." European Respiratory Journal 21.1 (2003): 58-67. Web. 16 Oct. 2019.

  2. Fattorini, L.

    1. Migliori, G.B. et al "Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998–2000." European Respiratory Journal 21.1 (2003): 129-134. Web. 16 Oct. 2019.

  3. Fesler, P.

    1. Fesler, P. et al "Single arterial occlusion to locate resistance in patients with pulmonary hypertension." European Respiratory Journal 21.1 (2003): 31-36. Web. 16 Oct. 2019.

G

  1. Garg, M.L.

    1. Wood, L.G., P.G. Gibson, and M.L. Garg. "Biomarkers of lipid peroxidation, airway inflammation and asthma." European Respiratory Journal 21.1 (2003): 177-186. Web. 16 Oct. 2019.

  2. Geddes, D.M.

    1. McShane, D. et al "Airway surface pH in subjects with cystic fibrosis." European Respiratory Journal 21.1 (2003): 37-42. Web. 16 Oct. 2019.

  3. Gibson, P.G.

    1. Wood, L.G., P.G. Gibson, and M.L. Garg. "Biomarkers of lipid peroxidation, airway inflammation and asthma." European Respiratory Journal 21.1 (2003): 177-186. Web. 16 Oct. 2019.

  4. Gori, A.

    1. Migliori, G.B. et al "Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998–2000." European Respiratory Journal 21.1 (2003): 129-134. Web. 16 Oct. 2019.

  5. Grangård, E.H.

    1. Lindbæk, M. et al "Socioeconomical conditions as risk factors for bronchial asthma in children aged 4–5 yrs." European Respiratory Journal 21.1 (2003): 105-108. Web. 16 Oct. 2019.

  6. Greenberg, J.

    1. Phillips, M. et al "Effect of oxygen on breath markers of oxidative stress." European Respiratory Journal 21.1 (2003): 48-51. Web. 16 Oct. 2019.

  7. Griese, M.

    1. Ratjen, F. et al "Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis." European Respiratory Journal 21.1 (2003): 144-148. Web. 16 Oct. 2019.

  8. Grigg, J.

    1. Oommen, A., and J. Grigg. "Urinary leukotriene E4 in preschool children with acute clinical viral wheeze." European Respiratory Journal 21.1 (2003): 149-154. Web. 16 Oct. 2019.

  9. Grodman, R.

    1. Phillips, M. et al "Effect of oxygen on breath markers of oxidative stress." European Respiratory Journal 21.1 (2003): 48-51. Web. 16 Oct. 2019.

  10. Grunewald, J.

    1. Planck, A., A. Eklund, and J. Grunewald. "Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients." European Respiratory Journal 21.1 (2003): 52-57. Web. 16 Oct. 2019.

  11. Grzanka, P.

    1. Nizankowska-Mogilnicka, E. et al "Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis." European Respiratory Journal 21.1 (2003): 25-30. Web. 16 Oct. 2019.

  12. Guerra, S.

    1. Sherrill, D. et al "The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics." European Respiratory Journal 21.1 (2003): 95-10. Web. 16 Oct. 2019.

  13. Gunawardena, R.

    1. Phillips, M. et al "Effect of oxygen on breath markers of oxidative stress." European Respiratory Journal 21.1 (2003): 48-51. Web. 16 Oct. 2019.

H

  1. Hernandez, C.

    1. Hernandez, C. et al "Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients." European Respiratory Journal 21.1 (2003): 58-67. Web. 16 Oct. 2019.

  2. Hiwada, K.

    1. Irifune, K. et al "T‐helper 1 cells induce alveolitis but do not lead to pulmonary fibrosis in mice." European Respiratory Journal 21.1 (2003): 11-18. Web. 16 Oct. 2019.

  3. Höffken, G.

    1. Torres, A. et al "Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia." European Respiratory Journal 21.1 (2003): 135-143. Web. 16 Oct. 2019.

  4. Hubloue, I.

    1. Hubloue, I. et al "Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction." European Respiratory Journal 21.1 (2003): 19-24. Web. 16 Oct. 2019.

I

  1. Irifune, K.

    1. Irifune, K. et al "T‐helper 1 cells induce alveolitis but do not lead to pulmonary fibrosis in mice." European Respiratory Journal 21.1 (2003): 11-18. Web. 16 Oct. 2019.

J

  1. Jones, P.W.

    1. Jones, P.W. et al "Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations." European Respiratory Journal 21.1 (2003): 68-73. Web. 16 Oct. 2019.

  2. Joos, G.F.

    1. Tournoy, K.G. et al "Modulatory role of tachykinin NK1 receptor in cholinergic contraction of mouse trachea." European Respiratory Journal 21.1 (2003): 3-10. Web. 16 Oct. 2019.

K

  1. Kafi, S. Abdel

    1. Hubloue, I. et al "Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction." European Respiratory Journal 21.1 (2003): 19-24. Web. 16 Oct. 2019.

  2. Kerbaul, F.

    1. Hubloue, I. et al "Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction." European Respiratory Journal 21.1 (2003): 19-24. Web. 16 Oct. 2019.

  3. Kharitonov, S.A.

    1. Paredi, P., S.A. Kharitonov, and P.J. Barnes. "Exhaled breath temperature in asthma." European Respiratory Journal 21.1 (2003): 195. Web. 16 Oct. 2019.
    2. Paredi, P., S.A. Kharitonov, and P.J. Barnes. "Exhaled carbon monoxide in lung disease." European Respiratory Journal 21.1 (2003): 197. Web. 16 Oct. 2019.
    3. Wodehouse, T. et al "Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia." European Respiratory Journal 21.1 (2003): 43-47. Web. 16 Oct. 2019.

  4. Kohno, N.

    1. Irifune, K. et al "T‐helper 1 cells induce alveolitis but do not lead to pulmonary fibrosis in mice." European Respiratory Journal 21.1 (2003): 11-18. Web. 16 Oct. 2019.

  5. Krzanowski, M.

    1. Nizankowska-Mogilnicka, E. et al "Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis." European Respiratory Journal 21.1 (2003): 25-30. Web. 16 Oct. 2019.

  6. Kubin, R.

    1. Torres, A. et al "Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia." European Respiratory Journal 21.1 (2003): 135-143. Web. 16 Oct. 2019.

L

  1. Leclere, P.G.

    1. Tournoy, K.G. et al "Modulatory role of tachykinin NK1 receptor in cholinergic contraction of mouse trachea." European Respiratory Journal 21.1 (2003): 3-10. Web. 16 Oct. 2019.

  2. Leeman, M.

    1. Hubloue, I. et al "Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction." European Respiratory Journal 21.1 (2003): 19-24. Web. 16 Oct. 2019.

  3. Lefebvre, R.A.

    1. Tournoy, K.G. et al "Modulatory role of tachykinin NK1 receptor in cholinergic contraction of mouse trachea." European Respiratory Journal 21.1 (2003): 3-10. Web. 16 Oct. 2019.

  4. Lemaigre, V.

    1. Put, C. et al "Evaluation of an individualised asthma programme directed at behavioural change." European Respiratory Journal 21.1 (2003): 109-115. Web. 16 Oct. 2019.

  5. Lindbæk, M.

    1. Lindbæk, M. et al "Socioeconomical conditions as risk factors for bronchial asthma in children aged 4–5 yrs." European Respiratory Journal 21.1 (2003): 105-108. Web. 16 Oct. 2019.

  6. Lu, S.

    1. Baumgartner, R.A. et al "Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone." European Respiratory Journal 21.1 (2003): 123-128. Web. 16 Oct. 2019.

  7. Lundberg, J.O.N.

    1. Zetterquist, W., J.O.N. Lundberg, and K. Alving. "Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis." European Respiratory Journal 21.1 (2003): 197-198. Web. 16 Oct. 2019.

M

  1. Mackay, I.S.

    1. Wodehouse, T. et al "Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia." European Respiratory Journal 21.1 (2003): 43-47. Web. 16 Oct. 2019.

  2. Martinez, G.

    1. Baumgartner, R.A. et al "Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone." European Respiratory Journal 21.1 (2003): 123-128. Web. 16 Oct. 2019.

  3. McShane, D.

    1. McShane, D. et al "Airway surface pH in subjects with cystic fibrosis." European Respiratory Journal 21.1 (2003): 37-42. Web. 16 Oct. 2019.

  4. Menga, G.

    1. Szafranski, W. et al "Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease." European Respiratory Journal 21.1 (2003): 74-81. Web. 16 Oct. 2019.

  5. Migliori, G.B.

    1. Migliori, G.B. et al "Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998–2000." European Respiratory Journal 21.1 (2003): 129-134. Web. 16 Oct. 2019.

  6. Milic-Emili, J.

    1. Di Marco, F. et al "Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD." European Respiratory Journal 21.1 (2003): 86-94. Web. 16 Oct. 2019.

  7. Muir, J-F.

    1. Torres, A. et al "Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia." European Respiratory Journal 21.1 (2003): 135-143. Web. 16 Oct. 2019.

N

  1. Naeije, R.

    1. Hubloue, I. et al "Endogenous endothelins and nitric oxide in hypoxic pulmonary vasoconstriction." European Respiratory Journal 21.1 (2003): 19-24. Web. 16 Oct. 2019.
    2. Fesler, P. et al "Single arterial occlusion to locate resistance in patients with pulmonary hypertension." European Respiratory Journal 21.1 (2003): 31-36. Web. 16 Oct. 2019.

  2. Nahabedian, S.

    1. Szafranski, W. et al "Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease." European Respiratory Journal 21.1 (2003): 74-81. Web. 16 Oct. 2019.

  3. Naidu, A.

    1. Phillips, M. et al "Effect of oxygen on breath markers of oxidative stress." European Respiratory Journal 21.1 (2003): 48-51. Web. 16 Oct. 2019.

  4. Nizankowska-Mogilnicka, E.

    1. Nizankowska-Mogilnicka, E. et al "Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis." European Respiratory Journal 21.1 (2003): 25-30. Web. 16 Oct. 2019.

  5. Nowak, D.

    1. Schramm, B. et al "Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1‐yr retrospective study." European Respiratory Journal 21.1 (2003): 116-122. Web. 16 Oct. 2019.

O

  1. Olsson, H.

    1. Szafranski, W. et al "Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease." European Respiratory Journal 21.1 (2003): 74-81. Web. 16 Oct. 2019.

  2. Oommen, A.

    1. Oommen, A., and J. Grigg. "Urinary leukotriene E4 in preschool children with acute clinical viral wheeze." European Respiratory Journal 21.1 (2003): 149-154. Web. 16 Oct. 2019.

  3. Orefici, G.

    1. Migliori, G.B. et al "Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998–2000." European Respiratory Journal 21.1 (2003): 129-134. Web. 16 Oct. 2019.

  4. Øvsthus, K.

    1. Lindbæk, M. et al "Socioeconomical conditions as risk factors for bronchial asthma in children aged 4–5 yrs." European Respiratory Journal 21.1 (2003): 105-108. Web. 16 Oct. 2019.

P

  1. Pagnamenta, A.

    1. Fesler, P. et al "Single arterial occlusion to locate resistance in patients with pulmonary hypertension." European Respiratory Journal 21.1 (2003): 31-36. Web. 16 Oct. 2019.

  2. Paredi, P.

    1. Paredi, P., S.A. Kharitonov, and P.J. Barnes. "Exhaled breath temperature in asthma." European Respiratory Journal 21.1 (2003): 195. Web. 16 Oct. 2019.
    2. Paredi, P., S.A. Kharitonov, and P.J. Barnes. "Exhaled carbon monoxide in lung disease." European Respiratory Journal 21.1 (2003): 197. Web. 16 Oct. 2019.

  3. Paul, K.

    1. Ratjen, F. et al "Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis." European Respiratory Journal 21.1 (2003): 144-148. Web. 16 Oct. 2019.

  4. Pauwels, R.A.

    1. Tournoy, K.G. et al "Modulatory role of tachykinin NK1 receptor in cholinergic contraction of mouse trachea." European Respiratory Journal 21.1 (2003): 3-10. Web. 16 Oct. 2019.

  5. Pecchiari, M.

    1. Santus, P. et al "Bronchodilation test in COPD: effect of inspiratory manoeuvre preceding forced expiration." European Respiratory Journal 21.1 (2003): 82-85. Web. 16 Oct. 2019.

  6. Peroni, D.G.

    1. Piacentini, G.L. et al "From the Authors." European Respiratory Journal 21.1 (2003): 196. Web. 16 Oct. 2019.

  7. Peterson, S.

    1. Szafranski, W. et al "Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease." European Respiratory Journal 21.1 (2003): 74-81. Web. 16 Oct. 2019.

  8. Phillips, M.

    1. Phillips, M. et al "Effect of oxygen on breath markers of oxidative stress." European Respiratory Journal 21.1 (2003): 48-51. Web. 16 Oct. 2019.

  9. Piacentini, G.L.

    1. Piacentini, G.L. et al "From the Authors." European Respiratory Journal 21.1 (2003): 196. Web. 16 Oct. 2019.

  10. Piersimoni, C.

    1. Migliori, G.B. et al "Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998–2000." European Respiratory Journal 21.1 (2003): 129-134. Web. 16 Oct. 2019.

  11. Planck, A.

    1. Planck, A., A. Eklund, and J. Grunewald. "Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients." European Respiratory Journal 21.1 (2003): 52-57. Web. 16 Oct. 2019.

  12. Poletti, V.

    1. Bonaccorsi, A. et al "Acute interstitial pneumonia: report of a series." European Respiratory Journal 21.1 (2003): 187-191. Web. 16 Oct. 2019.

  13. Polis, A.

    1. Baumgartner, R.A. et al "Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone." European Respiratory Journal 21.1 (2003): 123-128. Web. 16 Oct. 2019.

  14. Postma, D.S.

    1. Postma, D.S., N. Pride, and G. Viegi. "Benjamin Burrows, MD, 1927–2002." European Respiratory Journal 21.1 (2003): 200. Web. 16 Oct. 2019.

  15. Postmus, P.E.

    1. Roeleveld, R.J. et al "Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung." European Respiratory Journal 21.1 (2003): 192-194. Web. 16 Oct. 2019.

  16. Pride, N.

    1. Postma, D.S., N. Pride, and G. Viegi. "Benjamin Burrows, MD, 1927–2002." European Respiratory Journal 21.1 (2003): 200. Web. 16 Oct. 2019.

  17. Puig-Junoy, J.

    1. Hernandez, C. et al "Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients." European Respiratory Journal 21.1 (2003): 58-67. Web. 16 Oct. 2019.

  18. Put, C.

    1. Put, C. et al "Evaluation of an individualised asthma programme directed at behavioural change." European Respiratory Journal 21.1 (2003): 109-115. Web. 16 Oct. 2019.

Q

  1. Quednau, K.

    1. Schramm, B. et al "Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1‐yr retrospective study." European Respiratory Journal 21.1 (2003): 116-122. Web. 16 Oct. 2019.

R

  1. Rabe, K.F.

    1. Sterk, P.J., and K.F. Rabe. "You've got mail: erj@lumc.nl." European Respiratory Journal 21.1 (2003): 1-2. Web. 16 Oct. 2019.

  2. Ramirez, A.

    1. Szafranski, W. et al "Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease." European Respiratory Journal 21.1 (2003): 74-81. Web. 16 Oct. 2019.

  3. Ratjen, F.

    1. Ratjen, F. et al "Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis." European Respiratory Journal 21.1 (2003): 144-148. Web. 16 Oct. 2019.

  4. Reiss, T.F.

    1. Baumgartner, R.A. et al "Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone." European Respiratory Journal 21.1 (2003): 123-128. Web. 16 Oct. 2019.

  5. Roca, J.

    1. Hernandez, C. et al "Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients." European Respiratory Journal 21.1 (2003): 58-67. Web. 16 Oct. 2019.

  6. Rodriguez-Roisin, R.

    1. Hernandez, C. et al "Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients." European Respiratory Journal 21.1 (2003): 58-67. Web. 16 Oct. 2019.

  7. Rodriguez Gomez, G.G.

    1. Baumgartner, R.A. et al "Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone." European Respiratory Journal 21.1 (2003): 123-128. Web. 16 Oct. 2019.

  8. Roeleveld, R.J.

    1. Roeleveld, R.J. et al "Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung." European Respiratory Journal 21.1 (2003): 192-194. Web. 16 Oct. 2019.

  9. Rubin, L.J.

    1. Fesler, P. et al "Single arterial occlusion to locate resistance in patients with pulmonary hypertension." European Respiratory Journal 21.1 (2003): 31-36. Web. 16 Oct. 2019.

S

  1. Sagnier, P-P.

    1. Torres, A. et al "Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia." European Respiratory Journal 21.1 (2003): 135-143. Web. 16 Oct. 2019.

  2. Sakai, K.

    1. Irifune, K. et al "T‐helper 1 cells induce alveolitis but do not lead to pulmonary fibrosis in mice." European Respiratory Journal 21.1 (2003): 11-18. Web. 16 Oct. 2019.

  3. Saltini, C.

    1. Migliori, G.B. et al "Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998–2000." European Respiratory Journal 21.1 (2003): 129-134. Web. 16 Oct. 2019.

  4. Sanak, M.

    1. Nizankowska-Mogilnicka, E. et al "Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis." European Respiratory Journal 21.1 (2003): 25-30. Web. 16 Oct. 2019.

  5. Sansores, R.

    1. Szafranski, W. et al "Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease." European Respiratory Journal 21.1 (2003): 74-81. Web. 16 Oct. 2019.

  6. Santus, P.

    1. Santus, P. et al "Bronchodilation test in COPD: effect of inspiratory manoeuvre preceding forced expiration." European Respiratory Journal 21.1 (2003): 82-85. Web. 16 Oct. 2019.
    2. Di Marco, F. et al "Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD." European Respiratory Journal 21.1 (2003): 86-94. Web. 16 Oct. 2019.

  7. Schramm, B.

    1. Schramm, B. et al "Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1‐yr retrospective study." European Respiratory Journal 21.1 (2003): 116-122. Web. 16 Oct. 2019.

  8. Sherrill, D.

    1. Sherrill, D. et al "The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics." European Respiratory Journal 21.1 (2003): 95-10. Web. 16 Oct. 2019.

  9. Smala, A.

    1. Schramm, B. et al "Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1‐yr retrospective study." European Respiratory Journal 21.1 (2003): 116-122. Web. 16 Oct. 2019.

  10. Sterk, P.J.

    1. Sterk, P.J., and K.F. Rabe. "You've got mail: erj@lumc.nl." European Respiratory Journal 21.1 (2003): 1-2. Web. 16 Oct. 2019.

  11. Suissa, S.

    1. Suissa, S., and P. Ernst. "Use of anti-inflammatory therapy and asthma mortality in Japan." European Respiratory Journal 21.1 (2003): 101-104. Web. 16 Oct. 2019.

  12. Szafranski, W.

    1. Szafranski, W. et al "Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease." European Respiratory Journal 21.1 (2003): 74-81. Web. 16 Oct. 2019.

  13. Szczeklik, A.

    1. Nizankowska-Mogilnicka, E. et al "Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis." European Respiratory Journal 21.1 (2003): 25-30. Web. 16 Oct. 2019.

T

  1. Torres, A.

    1. Torres, A. et al "Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia." European Respiratory Journal 21.1 (2003): 135-143. Web. 16 Oct. 2019.

  2. Tournoy, K.G.

    1. Tournoy, K.G. et al "Modulatory role of tachykinin NK1 receptor in cholinergic contraction of mouse trachea." European Respiratory Journal 21.1 (2003): 3-10. Web. 16 Oct. 2019.

  3. Trisolini, R.

    1. Bonaccorsi, A. et al "Acute interstitial pneumonia: report of a series." European Respiratory Journal 21.1 (2003): 187-191. Web. 16 Oct. 2019.

V

  1. Vachiéry, J‐L.

    1. Fesler, P. et al "Single arterial occlusion to locate resistance in patients with pulmonary hypertension." European Respiratory Journal 21.1 (2003): 31-36. Web. 16 Oct. 2019.

  2. van den Bergh, O.

    1. Put, C. et al "Evaluation of an individualised asthma programme directed at behavioural change." European Respiratory Journal 21.1 (2003): 109-115. Web. 16 Oct. 2019.

  3. van der Bij, W.

    1. Roeleveld, R.J. et al "Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung." European Respiratory Journal 21.1 (2003): 192-194. Web. 16 Oct. 2019.

  4. Verleden, G.

    1. Put, C. et al "Evaluation of an individualised asthma programme directed at behavioural change." European Respiratory Journal 21.1 (2003): 109-115. Web. 16 Oct. 2019.

  5. Viegi, G.

    1. Postma, D.S., N. Pride, and G. Viegi. "Benjamin Burrows, MD, 1927–2002." European Respiratory Journal 21.1 (2003): 200. Web. 16 Oct. 2019.

  6. Vilagut, G.

    1. Hernandez, C. et al "Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients." European Respiratory Journal 21.1 (2003): 58-67. Web. 16 Oct. 2019.

  7. Vonk Noordegraaf, A.

    1. Roeleveld, R.J. et al "Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung." European Respiratory Journal 21.1 (2003): 192-194. Web. 16 Oct. 2019.

W

  1. Wefring, K.W.

    1. Lindbæk, M. et al "Socioeconomical conditions as risk factors for bronchial asthma in children aged 4–5 yrs." European Respiratory Journal 21.1 (2003): 105-108. Web. 16 Oct. 2019.

  2. Widlitz, A.

    1. Widlitz, A., and R.J. Barst. "Pulmonary arterial hypertension in children." European Respiratory Journal 21.1 (2003): 155-176. Web. 16 Oct. 2019.

  3. Willits, L.R.

    1. Jones, P.W. et al "Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations." European Respiratory Journal 21.1 (2003): 68-73. Web. 16 Oct. 2019.

  4. Wilson, R.

    1. Wodehouse, T. et al "Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia." European Respiratory Journal 21.1 (2003): 43-47. Web. 16 Oct. 2019.

  5. Wodehouse, T.

    1. Wodehouse, T. et al "Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia." European Respiratory Journal 21.1 (2003): 43-47. Web. 16 Oct. 2019.

  6. Wood, L.G.

    1. Wood, L.G., P.G. Gibson, and M.L. Garg. "Biomarkers of lipid peroxidation, airway inflammation and asthma." European Respiratory Journal 21.1 (2003): 177-186. Web. 16 Oct. 2019.

Y

  1. Yokoyama, A.

    1. Irifune, K. et al "T‐helper 1 cells induce alveolitis but do not lead to pulmonary fibrosis in mice." European Respiratory Journal 21.1 (2003): 11-18. Web. 16 Oct. 2019.

Z

  1. Zanolla, L.

    1. Piacentini, G.L. et al "From the Authors." European Respiratory Journal 21.1 (2003): 196. Web. 16 Oct. 2019.

  2. Zerman, L.

    1. Piacentini, G.L. et al "From the Authors." European Respiratory Journal 21.1 (2003): 196. Web. 16 Oct. 2019.

  3. Zetterquist, W.

    1. Zetterquist, W., J.O.N. Lundberg, and K. Alving. "Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis." European Respiratory Journal 21.1 (2003): 197-198. Web. 16 Oct. 2019.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts